Clinical Trials Directory

Trials / Sponsors / NovelMed Therapeutics

NovelMed Therapeutics

Industry · 9 registered clinical trials — 8 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
IgA Nephropathy
Phase 22028-02-01
Not Yet RecruitingStudy of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
aHUS - Atypical Hemolytic Uremic Syndrome
Phase 22027-11-01
Not Yet RecruitingStudy of NM8074 in Adult C3 Glomerulopathy Patients
C3 Glomerulopathy
Phase 1 / Phase 22027-05-01
Not Yet RecruitingStudy of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
Paroxysmal Nocturnal Hemoglobinuria
Phase 22027-01-01
Not Yet RecruitingStudy of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 22026-06-01
Not Yet RecruitingStudy of NM8074 in Patients with Dermatomyositis (DM)
Dermatomyositis
Phase 22026-06-01
Not Yet RecruitingStudy of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PNH - Paroxysmal Nocturnal Hemoglobinuria
Phase 22026-06-01
Not Yet RecruitingStudy of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
Paroxysmal Nocturnal Hemoglobinuria
Phase 22026-04-01
CompletedFirst-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult Volunteers
Healthy
Phase 12020-08-12